RotaTeq
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for RotaTeq, covering 2009-02-19 to 2025-12-18. Get the full timeline:
Most recent: EMA Authorised: RotaTeq (rotavirus serotype G1;rotavirus serotype G2;rotavirus serotype G3;rotavirus serotype G4;rotavirus serotype P1) — Merck Sharp & Dohme B.V.